RTI Biologics (Nasdaq: RTIX) reports Q1 EPS of $0.02, cents better than the analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE